|
|
|
| |
|
|
| |
The latest pharmacy / pharmacology news from News Medical |
|
|
|
 | | |
 Measuring Spectral Transmission of Pharmaceutical Containers in Accordance with USP <661.2>
Protecting pharmaceutical products starts with the right packaging. USP <661.2> establishes key performance standards for pharmaceutical and dietary supplement containers, helping ensure product quality and shelf-life. Discover how the PerkinElmer LAMBDA™ 1050+ UV/Vis/NIR spectrophotometer enables fast, reliable spectral transmission testing of plastic containers to support USP <661.2> compliance.
| |
|
|
|  | | | | |  New discovery advances sustainable production of plant-based medicines Two plants that cause neurotoxicity and paralysis in the tiniest doses are also known to counter pain, malaria, cancer and pests. | |  | | | | |  'Me-too' drugs drive increased spending through higher prescribing A long-running debate over prescription drug costs has centered on whether drug manufacturers are better rewarded for truly innovative medicines or so-called "me-too" drugs that may offer only incremental improvements over existing treatments but still command high prices. | | | | | | |  Insilico Medicine nominates powerful oral drug candidate for the management of heart risks Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the nomination of ISM0900, a potent, AI-driven, highly selective, orally available small molecule inhibitor of lipoprotein(a), or Lp(a), as a preclinical candidate (PCC) for the management of cardiovascular risks. | | | | | | |  Ion channel TPC1 identified as key regulator of iron homeostasis Researchers have deciphered the role of an ion channel in iron homeostasis, opening up new possibilities for treating iron metabolism disorders. | |
|
|
| | | | How would you rate today's newsletter?
| |
|
|
| | | |
 |
Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now. |
| |
|
|
|
|
|
|
|
